STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2023

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2023-01-01 to 2023-12-31
Filed
2024-11-05
IRS object ID
202403109349301805
Schema version
2023v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2024-11-05T10:47:44-06:00ReturnTs
Tax Period End2023-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1TWO INTERNATIONAL PLACE 22ND FLOORAddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02110ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2023-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INNOVATION ORGANIZATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlBIOTBusinessNameControlTxt
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 NEW YORK AVE NW NO 1300AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20005ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSTEPHEN JASKOPersonNm
Person TitleCFO & EVP OF BUSN DEVELOPMENTPersonTitleTxt
Phone2029629200PhoneNum
Signature2024-10-30SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonLAURA J KENNEYPreparerPersonNm
PTINP00202198PTIN
Phone6177170831PhoneNum
Preparation2024-10-29PreparationDt
FieldValueIRS element (for citing)
Tax2023TaxYr
Build TS2024-10-15 13:58:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerJOHN CROWLEYPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 NEW YORK AVE NW NO 1300AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20005ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$119,913,579GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501cYes (X)Organization501cInd
Website AddressWWW.BIO.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1981FormationYr
Legal Domicile StateDCLegalDomicileStateCd
Activity Or MissionBIO IS THE WORLD'S LARGEST ADVOCACY ASSOCIATION REPRESENTING APPROXIMATELY 1,000 MEMBER COMPANIES, STATE BIOTECHNOLOGY GROUPS, ACADEMIC AND RESEARCH INSTITUTIONS, PATIENT GROUPS, AND RELATED ORGANIZATIONS ACROSS THE UNITED STATES AND IN 30+ COUNTRIES. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. BIO'S EFFORTS INCLUDE ADVOCACY AND POLICY EFFORTS FOCUSED ON THE INNOVATIVE HEALTH OF THE SECTOR ALONG WITH CONVENING EVENTS AND OFFERING OTHER MEMBER SERVICES.ActivityOrMissionDesc
Voting Members Governing Body87VotingMembersGoverningBodyCnt
Voting Members Independent87VotingMembersIndependentCnt
Total Employee181TotalEmployeeCnt
Total Volunteers107TotalVolunteersCnt
Total Gross UBI$54,700TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$40,945NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$874,632PYContributionsGrantsAmt
CY Contributions Grants$0CYContributionsGrantsAmt
PY Program Service Revenue$77,932,917PYProgramServiceRevenueAmt
CY Program Service Revenue$93,460,509CYProgramServiceRevenueAmt
PY Investment Income$3,416,988PYInvestmentIncomeAmt
CY Investment Income$2,221,609CYInvestmentIncomeAmt
PY Other Revenue$20,960,638PYOtherRevenueAmt
CY Other Revenue$18,086,391CYOtherRevenueAmt
PY Total Revenue$103,185,175PYTotalRevenueAmt
CY Total Revenue$113,768,509CYTotalRevenueAmt
PY Grants And Similar Paid$711,285PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$1,534,902CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$33,487,118PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$39,078,972CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$52,145,707PYOtherExpensesAmt
CY Other Expenses$51,016,290CYOtherExpensesAmt
PY Total Expenses$86,344,110PYTotalExpensesAmt
CY Total Expenses$91,630,164CYTotalExpensesAmt
PY Revenues Less Expenses$16,841,065PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$22,138,345CYRevenuesLessExpensesAmt
Total Assets BOY$124,412,600TotalAssetsBOYAmt
Total Assets EOY$156,639,347TotalAssetsEOYAmt
Total Liabilities BOY$73,648,403TotalLiabilitiesBOYAmt
Total Liabilities EOY$79,279,320TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$50,764,197NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$77,360,027NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
DescADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE THREE SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS FOR THE YEAR ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT PROACTIVELY ADVANCING THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.- ADVOCATED FOR THE MODERNIZATION OF THE CLINICAL DEVELOPMENT PARADIGM.THE EMERGING COMPANIES SECTION ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR FISCAL POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE AGRICULTURE & ENVIRONMENT SECTION ADVOCACY ACCOMPLISHMENTS:BIO'S AGRICULTURE & ENVIRONMENT (OR AG & ENVIRONMENT) SECTION FOCUSES ON ISSUES RELATED TO THE ORGANIZATION'S PRIOR FOOD & AGRICULTURE AND INDUSTRIAL & ENVIRONMENT SECTIONS. THESE INCLUDE:- ADVOCATING ON INITIATIVES THAT STRENGTHEN THE BIOECONOMY; AND- MEETING SHARED GOALS RELATED TO SOCIETAL CHALLENGES SUCH AS FOOD SECURITY, NATIONAL SECURITY AND CLIMATE CHANGE.THE AG & ENVIRONMENT SECTION ADVOCATES AND COORDINATES DIRECTLY WITH GOVERNMENT AND INDUSTRY STAKEHOLDERS TO INCREASE THE UNDERSTANDING AND ACCEPTANCE OF BIOTECH INNOVATION, WHILE ALSO IMPROVING THE REGULATORY AND APPROVAL PROCESSES. THIS SECTION PROMOTES APPROPRIATE INITIATIVES THAT SUPPORT INNOVATION, MARKET ACCESS, AND MARKET ACCEPTANCE.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
DescSERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING ADVOCACY ACCOMPLISHMENTS LISTED BELOW:- SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT PROACTIVELY ADVANCING THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- BROUGHT TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINES DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 73 COUNTRIES AND 47 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA, PUERTO RICO AND THE US VIRGIN ISLANDS AND OFFERS PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.Desc
FieldValueIRS element (for citing)
Described In Section501c30DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Subject To Proxy TaxYes (1)SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other AssetsYes (1)ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document156IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee181EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryINForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (1)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members87GoverningBodyVotingMembersCnt
Independent Voting Member87IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn Body0Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSTEPHEN JASKOPersonNm
Phone2029629200PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 NEW YORK AVE NW STE 1300AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20005ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (114 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
GRACE E COLON
EMERGING COMPANIES SECT. VICE CHAIR2.00Yes (X)Yes (X)$0$0$0
JOHN F CROWLEY
HEALTH SECTION VICE CHAIR2.00Yes (X)Yes (X)$0$0$0
PAUL J HASTINGS
IMMEDIATE PAST CHAIR2.00Yes (X)Yes (X)$0$0$0
ELIZABETH LEWIS
ASSOCIATE VICE CHAIR & SECRETARY2.00Yes (X)Yes (X)$0$0$0
TED W LOVE
CHAIR2.00Yes (X)Yes (X)$0$0$0
ANNA RATH
AGRICULTURE & ENVIRONMENT SECT CHAIR2.00Yes (X)Yes (X)$0$0$0
DUANE J SIMPSON
AGRICULTURE & ENVIRONMENT VICE CHAIR2.00Yes (X)Yes (X)$0$0$0
ERIKA SMITH
EMERGING COMPANIES SECTION CHAIR2.00Yes (X)Yes (X)$0$0$0
SYLVIA WULF
AGRICULTURE & ENVIRONMENT SECT CHAIR2.00Yes (X)Yes (X)$0$0$0
BRADFORD A ZAKES
TREASURER2.00Yes (X)Yes (X)$0$0$0
ANGELA CARISA AILLONI
DIRECTOR2.00Yes (X)$0$0$0
STEVE ALBERS
DIRECTOR2.00Yes (X)$0$0$0
STUART A ARBUCKLE
DIRECTOR2.00Yes (X)$0$0$0
MARTIN BABLER
DIRECTOR2.00Yes (X)$0$0$0
SULAGNA BHATTACHARYA
DIRECTOR2.00Yes (X)$0$0$0
JEAN-JACQUES BIENAIME
DIRECTOR (UNTIL DECEMBER 2023)2.00Yes (X)$0$0$0
FRITZ BITTENBENDER
DIRECTOR2.00Yes (X)$0$0$0
ROBERT BLUM
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHER BOERNER
DIRECTOR (UNTIL JUNE 2023)2.00Yes (X)$0$0$0
CARRIE L BOURDOW
DIRECTOR2.00Yes (X)$0$0$0
CARINE BOUSTANY
DIRECTOR2.00Yes (X)$0$0$0
STEPHEN BRADY
DIRECTOR2.00Yes (X)$0$0$0
VICTOR BULTO
DIRECTOR2.00Yes (X)$0$0$0
EMMANUEL CAEYMAEX
DIRECTOR (UNTIL DECEMBER 2023)2.00Yes (X)$0$0$0
PABLO J CAGNONI
DIRECTOR (UNTIL OCTOBER 2023)2.00Yes (X)$0$0$0
KAY CHANDLER
DIRECTOR (UNTIL DECEMBER 2023)2.00Yes (X)$0$0$0
IVAN CHEUNG
DIRECTOR (UNTIL SEPTEMBER 2023)2.00Yes (X)$0$0$0
GIACOMO CHIESI
DIRECTOR2.00Yes (X)$0$0$0
JEFFREY L CLELAND
DIRECTOR2.00Yes (X)$0$0$0
RON COHEN
DIRECTOR2.00Yes (X)$0$0$0
BRUCE C COZADD
DIRECTOR2.00Yes (X)$0$0$0
ROGER CRYSTAL
DIRECTOR (UNTIL JUNE 2023)2.00Yes (X)$0$0$0
DOUGLAS DOERFLER
DIRECTOR (UNTIL DECEMBER 2023)2.00Yes (X)$0$0$0
ERIC M DUBE
DIRECTOR2.00Yes (X)$0$0$0
MARC DUNOYER
DIRECTOR2.00Yes (X)$0$0$0
MARK ENYEDY
DIRECTOR2.00Yes (X)$0$0$0
BARRY P FLANNELLY
DIRECTOR2.00Yes (X)$0$0$0
ALEXANDRIA FORBES
DIRECTOR2.00Yes (X)$0$0$0
KAYE FOSTER
DIRECTOR2.00Yes (X)$0$0$0
CEDRIC FRANCOIS
DIRECTOR2.00Yes (X)$0$0$0
DEBORAH GLASSER
DIRECTOR2.00Yes (X)$0$0$0
JOHN GLASSPOOL
DIRECTOR2.00Yes (X)$0$0$0
JENNIFER GOOD
DIRECTOR2.00Yes (X)$0$0$0
KEVIN C GORMAN
DIRECTOR2.00Yes (X)$0$0$0
YVONNE GREENSTREET
DIRECTOR2.00Yes (X)$0$0$0
SEBASTIAN GUTH
DIRECTOR2.00Yes (X)$0$0$0
KARIS GUTTER
DIRECTOR2.00Yes (X)$0$0$0
STEVEN HARR
DIRECTOR2.00Yes (X)$0$0$0
RACHEL HAURWITZ
DIRECTOR2.00Yes (X)$0$0$0
JENNIFER HOLMGREN
DIRECTOR2.00Yes (X)$0$0$0
MIKE HUCKMAN
DIRECTOR2.00Yes (X)$0$0$0
ELIZABETH JEFFORDS
DIRECTOR2.00Yes (X)$0$0$0
PATRIK JONSSON
DIRECTOR2.00Yes (X)$0$0$0
ALEX KARNAL
DIRECTOR (UNTIL OCTOBER 2023)2.00Yes (X)$0$0$0
DAVID KETTNER
DIRECTOR2.00Yes (X)$0$0$0
SCOTT KOENIG
DIRECTOR2.00Yes (X)$0$0$0
SAMARTH KULKARNI
DIRECTOR (UNTIL MAY 2023)2.00Yes (X)$0$0$0
JOSEPH J LAROSA
DIRECTOR2.00Yes (X)$0$0$0
CHRIS LEIBMAN
DIRECTOR2.00Yes (X)$0$0$0
JEREMY M LEVIN
DIRECTOR2.00Yes (X)$0$0$0
SANDY MACRAE
DIRECTOR2.00Yes (X)$0$0$0
GAIL MADERIS
DIRECTOR2.00Yes (X)$0$0$0
AAMIR MALIK
DIRECTOR (UNTIL DECEMBER 2023)2.00Yes (X)$0$0$0
ANTHONY MANCINI
DIRECTOR2.00Yes (X)$0$0$0
MAYA MARTINEZ-DAVIS
DIRECTOR2.00Yes (X)$0$0$0
SHARON MATES
DIRECTOR2.00Yes (X)$0$0$0
THOMAS P MATHERS
DIRECTOR2.00Yes (X)$0$0$0
REENIE MCCARTHY
DIRECTOR2.00Yes (X)$0$0$0
SHEILA ANN MIKHAIL
DIRECTOR2.00Yes (X)$0$0$0
ROCCO MORELLI
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL M MORRISSEY
DIRECTOR2.00Yes (X)$0$0$0
MICHAEL NARACHI
DIRECTOR (UNTIL FEBRUARY 2023)2.00Yes (X)$0$0$0
AMIR NASHAT
DIRECTOR2.00Yes (X)$0$0$0
WILLIAM J NEWELL
DIRECTOR2.00Yes (X)$0$0$0
ANDREW OBENSHAIN
DIRECTOR2.00Yes (X)$0$0$0
JANNIE OOSTHUIZEN
DIRECTOR2.00Yes (X)$0$0$0
CATHERINE OWEN
DIRECTOR2.00Yes (X)$0$0$0
JULIA OWENS
DIRECTOR2.00Yes (X)$0$0$0
JOHN V OYLER
DIRECTOR2.00Yes (X)$0$0$0
CINDY PERETTIE
DIRECTOR2.00Yes (X)$0$0$0
ADELENE Q PERKINS
DIRECTOR (UNTIL OCTOBER 2023)2.00Yes (X)$0$0$0
RICHARD POPS
DIRECTOR2.00Yes (X)$0$0$0
MARK PRUZANSKI
DIRECTOR2.00Yes (X)$0$0$0
SOFIE QIAO
DIRECTOR2.00Yes (X)$0$0$0
MIKE G RAAB
DIRECTOR2.00Yes (X)$0$0$0
ELENA RICE
DIRECTOR (UNTIL DECEMBER 2023)2.00Yes (X)$0$0$0
MICHAEL J RUGGIERO
DIRECTOR2.00Yes (X)$0$0$0
JAMES SAPIRSTEIN
DIRECTOR2.00Yes (X)$0$0$0
CHRISTOPHE SCHILLING
DIRECTOR2.00Yes (X)$0$0$0
HAROUT SEMERJIAN
DIRECTOR2.00Yes (X)$0$0$0
CHRISTI SHAW
DIRECTOR (UNTIL MARCH 2023)2.00Yes (X)$0$0$0
JEFFREY SHERMAN
DIRECTOR (UNTIL OCTOBER 2023)2.00Yes (X)$0$0$0
BILL SIBOLD
DIRECTOR (UNTIL SEPTEMBER 2023)2.00Yes (X)$0$0$0
NANCY SIMONIAN
DIRECTOR2.00Yes (X)$0$0$0
EDDIE J SULLIVAN
DIRECTOR2.00Yes (X)$0$0$0
IAN THOMPSON
DIRECTOR2.00Yes (X)$0$0$0
NOLAN TOWNSEND
DIRECTOR2.00Yes (X)$0$0$0
LINDA TROLINDER
DIRECTOR2.00Yes (X)$0$0$0
NEIL K WARMA
DIRECTOR2.00Yes (X)$0$0$0
SUE WASHER
DIRECTOR (UNTIL MARCH 2023)2.00Yes (X)$0$0$0
FRANK WATANABE
DIRECTOR2.00Yes (X)$0$0$0
SCOTT WHITE
DIRECTOR2.00Yes (X)$0$0$0
RICK E WINNINGHAM
DIRECTOR2.00Yes (X)$0$0$0
ROGER WYSE
DIRECTOR (UNTIL DECEMBER 2023)2.00Yes (X)$0$0$0
TATSUYUKI YASUNO
DIRECTOR2.00Yes (X)$0$0$0
DAPHNE ZOHAR
DIRECTOR2.00Yes (X)$0$0$0
STEPHEN JASKO
CHIEF FINANCIAL OFFICER, EVP BUSINESS DEVELOPMENT40.00Yes (X)$746,044$0$86,573
RACHEL K KING
INTERIM PRESIDENT AND CEO40.00Yes (X)$1,267,480$0$64,672
RICHARD MASTERS
CHIEF PUBLIC AFFAIRS & MARKETING OFFICER40.00$761,623$0$85,347Yes (X)
NICHOLAS SHIPLEY
CHIEF ADVOCACY OFFICER40.00$758,821$0$80,397Yes (X)
ELIZABETH ESHAM
CHIEF SCIENCE OFFICER40.00$737,273$0$56,912Yes (X)
PETER MCHUGH
CHIEF LEGAL OFFICER40.00$665,131$0$88,647Yes (X)
JOHN MURPHY
CHIEF POLICY OFFICER40.00$550,953$0$87,604Yes (X)
MICHELLE MCMURRY-HEATH
FORMER PRESIDENT AND CEO40.00$1,848,121$0$6,522Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$7,335,446TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$556,674TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K102IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (1)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
MLLC
217 CHURCH STPHILADELPHIAPA19106CREATIVE STRATEGY DIRECTION$1,000,835
THE SAMANTHA SAULT AGENCY LLC
2039 NEW HAMPSHIRE AVE NW SUITE 109WASHINGTONDC20009EDITORIAL SUPPORT$809,180
O'KEEFE COMMUNICATIONS LLC
2 BETHESDA METRO CENTER SUITE 310BETHESDAMD20814EVENT STAGING & LABOR$573,385
ARENT FOX SCHIFF LLP
1717 K ST NWWASHINGTONDC20006LEGAL SERVICES$484,772
HOGAN LOVELLS US LLP
555 THIRTEENTH ST NWWASHINGTONDC20004LEGAL SERVICES$444,207
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K25CntrctRcvdGreaterThan100KCnt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
CONFERENCE / MEETING R541800$54,127,908$54,073,208$54,700
MEMBERSHIP DUES900003$36,349,909$36,349,909
SPECIAL INITIATIVES900003$1,803,019$1,803,019
CBI LOBBYING FUND900003$996,773$996,773
OTHER PROGRAM SERVICES900003$182,900$182,900
FieldValueIRS element (for citing)
Total Program Service Revenue$93,460,509TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,063,448TotalRevenueColumnAmt
Exclusion$2,063,448ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$18,086,391TotalRevenueColumnAmt
Exclusion$18,086,391ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$6,303,231SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$6,145,070SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$158,161SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$158,161TotalRevenueColumnAmt
Exclusion$158,161ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$113,768,509TotalRevenueColumnAmt
Related Or Exempt Func Income$93,405,809RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$54,700UnrelatedBusinessRevenueAmt
Exclusion$20,308,000ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$1,496,597TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$38,305TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,164,769TotalAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$1,854,643TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$27,940,485TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$2,520,345TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$2,752,839TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,845,891TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$992,992TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$211,414TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$4,884,289TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$68,738TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$9,803,397TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$894,217TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$814,345TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,178,116TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$4,173,641TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,528,320TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$12,711,346TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$7,299,919TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$889,454TotalAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$371,457TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmt
DUES & MEMBERSHIP$1,438,534
BANK FEES$1,347,308
SUBSCRIPTIONS$816,211
TAXES PAID$375,093

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$217,499TotalAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$91,630,164TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$35,460,368BOYAmt
EOY$32,346,821EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,220,372BOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$7,153,037BOYAmt
EOY$5,320,200EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
EOY$78,566EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$3,329,669BOYAmt
EOY$4,097,309EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$15,642,351LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$2,737,090LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$11,698,887BOYAmt
EOY$12,905,261EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$44,601,716BOYAmt
EOY$80,707,801EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$20,948,551BOYAmt
EOY$21,183,389EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$124,412,600BOYAmt
EOY$156,639,347EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$17,018,984BOYAmt
EOY$12,067,134EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$16,155,091BOYAmt
EOY$21,531,353EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$40,474,328BOYAmt
EOY$45,680,833EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$73,648,403BOYAmt
EOY$79,279,320EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$50,764,197BOYAmt
EOY$77,360,027EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$50,764,197BOYAmt
EOY$77,360,027EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$124,412,600BOYAmt
EOY$156,639,347EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$22,138,345ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$4,457,485NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Substantially All Dues Nonded0SubstantiallyAllDuesNondedInd
Only In House Lobbying0OnlyInHouseLobbyingInd
Agree Carryover Prior YearYes (1)AgreeCarryoverPriorYearInd
Dues Assessments$35,730,185DuesAssessmentsAmt
Non Deductible Lbbyng Pltcl CY$10,819,819NonDeductibleLbbyngPltclCYAmt
Non Ded Lbbyng Pltcl Cyov-$3,162,162NonDedLbbyngPltclCyovAmt
Non Deductible Lbbyng Pltcl Tot$7,657,657NonDeductibleLbbyngPltclTotAmt
Aggregate Reported Dues Ntc$12,505,565AggregateReportedDuesNtcAmt
Carried Over-$4,847,908CarriedOverAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$9,664,399OtherCostOrOtherBasisAmt
Depreciation$1,031,923DepreciationAmt
Book Value$8,632,476BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,662,532OtherCostOrOtherBasisAmt
Depreciation$412,814DepreciationAmt
Book Value$2,249,718BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,315,420OtherCostOrOtherBasisAmt
Depreciation$1,292,353DepreciationAmt
Book Value$2,023,067BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$12,905,261TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDescBook ValueBookValueAmt
RIGHT OF USE ASSET - OPERATING$20,412,643
DEFERRED COMPENSATION INVESTMENTS$770,746
FieldValueIRS element (for citing)
Total Book Value Other Assets$21,183,389TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (8 entries)

DescDescAmtAmt
LEASE LIABILITY - OPERATING$41,836,734
BIO-PAC$218,733
DEFERRED COMPENSATION PLAN$770,746
STATE AFFILIATE$135,588
EVENT WITHHOLDING$96,650
SPECIAL INITIATIVES$2,444,577
UNAPPLIED RECEIPTS$140,390
OTHER$37,415
FieldValueIRS element (for citing)
Total Liability$45,680,833TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$118,280,948TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$4,457,485NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$123,692DonatedServicesAndUseFcltsAmt
Revenue Not Reported$4,581,177RevenueNotReportedAmt
Revenue Subtotal$113,699,771RevenueSubtotalAmt
Investment Expenses Not Incld$68,738InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$68,738RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$113,768,509TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$91,685,118TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$123,692DonatedServicesUseFcltsAmt
Expenses Not Reported$123,692ExpensesNotReportedAmt
Expenses Subtotal$91,561,426ExpensesSubtotalAmt
Investment Expenses Not Incld2$68,738InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$68,738ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$91,630,164TotalExpensesPerForm990Amt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EUROPE (INCLUDING ICELAND & GREENLAND)00PROGRAM SERVICESCONFERENCES, ADVOCACY AND EDUCATION$68,763
CENTRAL AMERICA AND THE CARIBBEAN00PROGRAM SERVICESCONFERENCES, ADVOCACY AND EDUCATION$25,000
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$93,763SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$93,763TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmtDescription Of Non Cash AsstDescriptionOfNonCashAsstTxtValuation Method UsedValuationMethodUsedDesc
CENTRAL AMERICA AND THE CARIBBEANTO SPONSOR THE PAVILION OF THE AMERICAS AGRI-FOOD SYSTEMS AT THE UN CLIMATE CHANGE CONFERENCE$25,000ACH TRANSFER$0
EUROPE (INCLUDING ICELAND & GREENLAND)COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO VENDOR$0$13,305BIO ASSOCIATE MEMBERSHIPFMV
FieldValueIRS element (for citing)
Total501c3 Org0Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:AS ATTENDEES OF THE EVENT SPONSORED IN 2023, BIO SEES HOW ITS SPONSORSHIP FUNDS WERE PUT TO USE AND BIO RECEIVES BENEFITS SUCH AS ACCESS TO THE PAVILION EVENTS AND RECEPTIONS.
PART I, LINE 3:THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO REPORT EXPENDITURES FOR ACTIVITIES OUTSIDE THE U.S..

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (60 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDescNon Cash AssistanceNonCashAssistanceDescPurpose Of GrantPurposeOfGrantTxtIRC SectionIRCSectionDescAddress Line2USAddress/AddressLine2Txt
ADP
99 JEFFERSON ROADPARSIPPANYNJ07054221467904$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
AIRGAS HEALTHCARE
259 N RADNOR CHESTER ROADRADNORPA19087560732648$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
ALLIANCE FOR AGING RESEARCH
1700 K STREET NW SUITE 740WASHINGTONDC20006541379174$10,000$0CONTRIBUTION501(C)(3)
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
555 11TH STREET SUITE 300WASHINGTONDC20004522340031$25,000$0SPONSORSHIP501(C)(4)
AMERICAN LABORATORY TRADING
12 COLTON ROADEAST LYMECT06333874749183$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
AON RISK SOLUTIONS
1650 MARKET STREET SUITE 1000 ONEPHILADELPHIAPA19103521448077$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDORLIBERTY PLACE
AVANTOR
100 MATSONFORD ROAD RADNOR CORPRADNORPA19087822758923$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDORCENTER BLDG 1 PO BOX 6660
BIOCOM CALIFORNIA
10996 TORREYANA RD STE 200SAN DIEGOCA92121330496646$5,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
BIO FLORIDA INC
6742 FOREST HILL BLVD 256WEST PALM BEACHFL33413593436638$5,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
BIO NJ INC
1255 WHITEHORSE-MERCERVILLE RDTRENTONNJ08619223284393$35,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)BUILDING B - SUITE 514
BIO VENTURES FOR GLOBAL HEALTH (BVGH)
2101 FOURTH AVENUE 1950SEATTLEWA98121300213137$50,000$0CONTRIBUTION501(C)(3)
BIOUTAH
PO BOX 58531SALT LAKE CITYUT841580531900899204$8,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
BREX
153 TOWNSEND STREET FLOOR 6SAN FRANCISCOCA94107364071727$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
CALIFORNIA LIFE SCIENCES ASSOCIATION
9605 SCRANTON ROAD SUITE 120SAN DIEGOCA92121473226523$13,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
CENTER FOR GLOBAL HEALTH INNOVATION INC
999 PEACHTREE STREET NE SUITE 1800ATLANTAGA30309581849665$35,000$0SPONSORSHIP501(C)(3)
CHUBB
202 HALLS MILLS ROAD PO BOX 1650WHITEHOUSE STATIONNJ08889132595722$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
CLEAN HARBORS
42 LONGWATER DRIVENORWELLMA02061042698999$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
COLORADO BIOSCIENCE ASSOCIATION
600 GRANT STREET SUITE 306DENVERCO80203841363258$12,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
COUNCIL FOR INNOVATION PROMOTION
1909 K STREET NWWASHINGTONDC20006882373877$15,000$0CONTRIBUTION501(C)(5)
DC BLACK CHURCH INITIATIVE
PO BOX 65177WASHINGTONDC20025522169774$10,000$0CONTRIBUTION501(C)(3)
DELAWARE BIOSCIENCE ASSOCIATION INC
PO BOX 7708WILMINGTONDE19803204147195$10,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
DEMOCRATIC GOVERNORS ASSOCIATION
C/O MEGHAN MEEHAN-DRAPER 1225 EYEWASHINGTONDC20005521304889$10,000$0CONTRIBUTION527STREET NW SUITE 1100
EPILEPSY FOUNDATION OF AMERICA
3540 CRAIN HIGHWAY SUITE 675BOWIEMD20716520856660$6,500$0CONTRIBUTION501(C)(3)
EVERYLIFE FOUNDATION FOR RARE DISEASES
1012 14TH ST NW SUITE 500WASHINGTONDC20005264614274$15,000$0SPONSORSHIP501(C)(3)
GEORGE MASON UNIVERSITY FOUNDATION INC
4400 UNIVERSITY DRIVE MSN 1A3ARLINGTONVA22030541603842$20,000$0CONTRIBUTION501(C)(3)
HAWAII CROP IMPROVEMENT ASSOCIATION
PO BOX 3717LIHNEHI96766990258882$27,500$0SPONSORSHIP501(C)(6)
HUMBOLDT STORAGE & MOVING
100 NEW BOSTON DRIVECANTONMA02021041375440$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
ILLINOIS BIOTECHNOLOGY INNOVATION ORGANIZATION (IBIO)
DBA IBIO 400 N ABERDEEN ST SUITECHICAGOIL60642364225980$25,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)900
INDIANA HEALTH INDUSTRY FORUM INC
429 E VERMONT STREET SUITE 304INDIANAPOLISIN46202351955274$4,000$2,758FMVBIO ASSOCIATE MEMBERSHIPCONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
IOWA BIOTECHNOLOGY ASSOCIATION
500 E COURT AVE SUITE 112DES MOINESIA50309391885797$5,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
LIFE SCIENCE WASHINGTON
1551 EASTLAKE AVE E SUITE 300SEATTLEWA98102911453398$7,500$2,758FMVBIO ASSOCIATE MEMBERSHIPCONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
LIFE SCIENCES PENNSYLVANIA
650 EAST SWEDESFORD RD SUITE 190WAYNEPA19087251621500$9,510$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
LUPUS FOUNDATION OF AMERICA INC
2121 K STREET NW SUITE 200WASHINGTONDC20037431131436$7,500$0CONTRIBUTION501(C)(3)
MARYLAND TECHNOLOGY COUNCIL INC
9841 WASHINGTONIAN BLVD SUITE 200GAITHERSBURGMD20878204950778$15,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
MISSOURI BIOTECHNOLOGY ASSOCIATION
428 EAST CAPITAL AVEJEFFERSON CITYMO65102431908699$5,000$2,758FMVBIO ASSOCIATE MEMBERSHIPCONTRIBUTION AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
MONTANA BIOSCIENCE ALLIANCE
P O BOX 1773BILLINGSMT59101833119423$15,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
NATIONAL HEALTH COUNCIL INC
1730 M STREET NW SUITE 500WASHINGTONDC200364561131624107$124,500$0SPONSORSHIP501(C)(3)
NATIONAL PSORIASIS FOUNDATION
6600 SW 92ND AVE SUITE 300PORTLANDOR97223930571472$5,750$0CONTRIBUTION AND SPONSORSHIP501(C)(3)
NEW YORK BIOTECHNOLOGY ASSOC
25 HEALTH SCIENCES DR SUITE 203STONY BROOKNY11790113026494$10,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
NIKON INSTRUMENTS
1300 WALT WHITMAN ROADMELVILLENY11747113554845$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
NORTH CAROLINA LIFE SCIENCES ORGANIZATION
PO BOX 14354RESEARCH TRIANGLE PARKNC27709561880780$8,375$2,758FMVBIO ASSOCIATE MEMBERSHIPCONTRIBUTION, SPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
ODP BUSINESS SOLUTIONS
6600 NORTH MILITARY TRAIL SUITE 900BOCA RATONFL33496862161688$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
OHIO LIFE SCIENCES ASSOCIATION
1275 KINNEAR RDCOLUMBUSOH43212920273822$5,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
OREGON BIOSCIENCE ASSOC
2828 SW CORBETT AVE SUITE 115PORTLANDOR97201931009329$4,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
PSC BIOTECH CORPORATION
700 CORPORATE CENTER DRIVEPOMONACA91768582239335$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
REPUBLICAN GOVERNORS ASSOCIATION
1747 PENNSYLVANIA AVE NWWASHINGTONDC20006113655877$10,000$0SPONSORSHIP527
REPUBLICAN STATE LEADERSHIP COMMITTEE
1201 F ST NW SUITE 675WASHINGTONDC20004050532524$25,000$0SPONSORSHIP527
SHAKESPEARE THEATRE COMPANY (STC)
DBA SHAKESPEARE THEATRE COMPANYWASHINGTONDC20003521405988$25,000$0CONTRIBUTION AND SPONSORSHIP501(C)(3)ATTN DEV OPERATIONS 516 8TH ST SE
SHAREVAULT
16795 LARK AVENUE SUITE 210LOS GATOSCA95032562407915$0$22,571FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
TEXAS HEALTHCARE & BIOSCIENCE INSTITUTE (THBI)
807 BRAZOS STREET SUITE 607AUSTINTX78701760501034$12,000$2,758FMVBIO ASSOCIATE MEMBERSHIPSPONSORSHIP AND COMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO STATE AFFILIATE501(C)(6)
THE ARTHRITIS FOUNDATION INC
1355 PEACHTREE ST NE SUITE 600ATLANTAGA30309581341679$15,000$0SPONSORSHIP501(C)(3)
THE GLOBAL WOMEN'S INNOVATION NETWORK (GLOBALWIN)
233 PENNSYLVANIA AVENUE SE 2NDWASHINGTONDC20003271428117$25,000$0CONTRIBUTION501(C)(3)FLOOR
THE GOVERNING MAJORITY EDUCATION FUND
606 W WISCONSIN AVE 1202MILWAUKEEWI53203850549304$25,000$0CONTRIBUTION501(C)(4)
THE WILLIAM E PROUDFORD SICKLE CELL FUND INC
445 BANK LANE UNIT 979DOVERDE19904810679590$10,000$0SPONSORSHIP501(C)(3)
UNIFIRST
68 JONSPIN ROADWILMINGTONMA01887042103460$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
UNITED SPINAL ASSOCIATION INC
120-34 QUEENS BLVD SUITE 320KEW GARDENSNY11415135612621$10,000$0SPONSORSHIP501(C)(3)
UPS
55 GLENLAKE PARKWAY NEATLANTAGA30328582480149$0$31,485FMVBIO ASSOCIATE MEMBERSHIPCOMPLIMENTARY ASSOCIATE MEMBERSHIP OF BIO BBS VENDOR
WASHINGTON LEGAL FOUNDATION
2009 MASSACHUSETTS AVE NWWASHINGTONDC20036521071570$20,000$0CONTRIBUTION501(C)(3)
WOMEN IN BIO INC
PO BOX 97900PITTSBURGHPA15227030458239$15,000$0SPONSORSHIP501(C)(3)
WOMEN OF COLOR IN PHARMA
PO BOX 6172SOMERSETNJ08873813871261$11,150$0SPONSORSHIP501(C)(6)
FieldValueIRS element (for citing)
Total501c3 Org17Total501c3OrgCnt
Total Other Org43TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationBIO RELIES ON THE REQUIRED QUALIFICATIONS OF THE CONTRIBUTION AND SPONSORSHIP RECIPIENTS TO PROVIDE ASSURANCE OF PROPER USAGE. IN SOME CASES, BIO PERSONNEL ATTEND EVENTS AND RECEIVE ACKNOWLEDGMENTS RELATED TO THE FUNDS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E ExpnssYes (1)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (1)SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MICHELLE MCMURRY-HEATH
FORMER PRESIDENT AND CEO$205,123$0$0$0$1,642,998$0$1,049$0$5,473$0$1,854,643$0$450,000$0
RACHEL K KING
INTERIM PRESIDENT AND CEO$1,267,480$0$0$0$0$0$33,477$0$31,195$0$1,332,152$0$0$0
RICHARD MASTERS
CHIEF PUBLIC AFFAIRS & MARKETING OFF$589,123$0$172,500$0$0$0$42,627$0$42,720$0$846,970$0$0$0
NICHOLAS SHIPLEY
CHIEF ADVOCACY OFFICER$586,321$0$172,500$0$0$0$37,898$0$42,499$0$839,218$0$0$0
STEPHEN JASKO
CHIEF FINANCIAL OFFICER, EVP BUSINES$538,992$0$207,052$0$0$0$42,627$0$43,946$0$832,617$0$0$0
ELIZABETH ESHAM
CHIEF SCIENCE OFFICER$551,720$0$185,553$0$0$0$41,124$0$15,788$0$794,185$0$0$0
PETER MCHUGH
CHIEF LEGAL OFFICER$499,884$0$165,247$0$0$0$42,627$0$46,020$0$753,778$0$0$0
JOHN MURPHY
CHIEF POLICY OFFICER$426,453$0$124,500$0$0$0$42,627$0$44,977$0$638,557$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1ATHE ORGANIZATION'S CEO WAS PERMITTED TO USE FIRST-CLASS FARES FOR BUSINESS TRAVEL PAID FOR BY THE ORGANIZATION. THE ORGANIZATION DID NOT TREAT FIRST-CLASS TRAVEL AS A TAXABLE FRINGE BENEFIT IN 2023.
PART I, LINES 4A-BIN 2023, MICHELLE MCMURRY-HEATH RECEIVED $1,002,820 IN SEPARATION PAYMENTS, AND $639,212 FROM HER NONQUALIFIED DEFERRED COMPENSATION PLAN.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1ATHE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN TWENTY-THREE (23) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE (EC). THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION; THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD (FB). IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FB, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FB SHALL BE SELECTED FOR THE EC. THE EC SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FB AS SET FORTH IN ARTICLE VI, SECTION 1(C) OF THE BYLAWS, EXCEPT THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION; TO CHANGE THE SIZE OF THE BOARD; AND TO ELECT OR REMOVE, OR MAKE DETERMINATIONS AS TO THE COMPENSATION OF THE DIRECTORS AND OFFICERS WHO ARE NOT EMPLOYEES OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 4THE BIO BOARD OF DIRECTORS APPROVED CHANGES TO BIO'S BYLAWS THAT DELEGATE GOVERNANCE AND DECISION-MAKING AUTHORITY FROM THE FULL BOARD OF DIRECTORS TO THE BOARD'S EXECUTIVE COMMITTEE. THE BIO BOARD OF DIRECTORS ALSO MADE CHANGES TO SIMPLIFY AND CLARIFY BIO'S BYLAWS, INCLUDING TERM LIMITS FOR CERTAIN DIRECTORS, RESPONSIBILITIES FOR THE TREASURER AND CHIEF FINANCIAL OFFICER, AND THE ROLES OF WORK GROUPS AND COMMITTEES IN BIO.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY FEWER THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS: ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS: ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS: ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AAT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS WITH INFORMATION PROVIDED BY AND UNDER THE GUIDANCE OF THE CHIEF FINANCIAL OFFICER (CFO). THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY KEY EMPLOYEES, OFFICERS AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH DIRECTOR ON ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15FOR 2023, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER (CEO) OF BIO (BIOTECHNOLOGY INNOVATION ORGANIZATION 52-1224577) WAS COMPENSATED PER THE TERMS OF A MULTI-YEAR CONTRACT THAT WAS DETERMINED WITH INDEPENDENT REVIEW, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, AS INDICATED IN PRIOR FORM 990 SUBMISSIONS. IN ADDITION, BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2023, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH THE RELEVANT PROVISION OF THE EXECUTIVE AGREEMENT. WHEN DETERMINING THE COMPENSATION OF THE BIO PRESIDENT & CEO, BIO HAS USED AN EXPERT OUTSIDE CONSULTANT TO BENCHMARK COMPENSATION. COMPENSATION OFTEN INCLUDES MORE THAN JUST SALARY AND BONUS, AND TO THIS END, BIO USES AN EXPERT OUTSIDE LEGAL COUNSEL WHO HAS EXTENSIVE EXPERIENCE IN NEGOTIATING THE TERMS OF CONTRACTS FOR THE PRESIDENT & CEO OF TRADE ASSOCIATIONS IN DC OF SIMILAR SIZE TO BIO. DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2023.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART IX, LINE 11GCONSULTANTS 6,772,604. EDUCATION & TRAINING 79,665. TEMPORARY STAFF 723,850. SPECIAL INITIATIVES 1,223,023. RECRUITING 1,004,255.